Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder
利用药物重定位策略开发一种新型疗法——替哌啶羟苯甲酸酯缓释片（TS-141），用于治疗儿童和青少年注意力缺陷/多动障碍。
期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-020-02932-2
Saito, Takuya; Yamashita, Yushiro; Tomoda, Akemi; Okada, Takashi; Umeuchi, Hideo; Iwamori, Saki; Shinoda, Satoru; Mizuno-Yasuhira, Akiko; Urano, Hidetoshi; Nishino, Izumi; Saito, Kazuhiko
